News Industry Updates Business Medical
Supreme Cannabis sends first shipment to Israel

Supreme Cannabis Company Inc. announced to its investors on April 2 that the company has completed its first international supply shipment from Canada to Israel.

Supreme Cannabis partnered with Breath of Life International Ltd. (BOL Pharma) to offer Truverra-branded premium medical cannabis to patients in Israel in 10-gram containers.

The company’s chief executive, Colin Moore, said this important milestone marks a new international revenue opportunity for the company.

“With the support of BOL Pharma, we navigated both Canada and Israel’s complex regulatory landscapes to achieve compliance with regulatory authorities in both countries, including Health Canada, the Canadian Food Inspection Agency andIsrael’s Ministry of Health and Ministry of Agriculture and Rural Development,” said Moore.

BOL Pharma has been involved in researching and developing cannabis-based products for 13 years. It is the largest medical cannabis company in Israel and the only one to handle all stages of cultivation and production, ensuring compliance with the strictest standards set by the Israeli Ministry of Health and EU-GMP conditions.

“On March 30, Truverra products became available across pharmacies in Israel and we are already receiving positive feedback from patients,” said Dr. Tamir Gedo, CEO of BOL Pharma. “We look forward to continuing to work with Supreme Cannabis and to offering Truverra’s premium medical cannabis to patients inIsrael.”